|
Name: 4-Bromo-2,5-dimethoxyamphetamine
Type:
AKA: DOB, 4-bromo-DMA
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
4-Bromo-2,5-dimethoxyamphetamine (DOB) is a psychedelic compound first synthesized in the 1960s. It is known for its potent hallucinogenic effects and long duration of action. DOB has been used in psychedelic research and has appeared in recreational drug markets. Its use is regulated due to the potential for abuse and psychological effects.
|
|
V. Legal Information
4-Bromo-2,5-dimethoxyamphetamine (4-Bromo-2,5-DMA) is a substituted amphetamine and is often regulated under analog laws due to its similarity to controlled substances. In the US, it could fall under the Federal Analog Act if deemed similar to other controlled substances. Globally, its legal status is restrictive, with many countries implementing controls on synthetic analogs to address potential abuse.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
4-Bromo-2,5-Dimethoxyamphetamine, a psychedelic, produces hallucinogenic effects. As an upper, it induces altered perception and euphoria. Short-term effects include visual and auditory hallucinations, while long-term use may lead to psychological issues. Overdose risks involve severe agitation and psychosis. Safe use involves cautious dosing and supervision. Recent findings highlight its hallucinogenic properties and potential for misuse.  |
|
VII. Psychological Effects
4-Bromo-2,5-dimethoxyamphetamine (4-Bromo-DMA) affects serotonin receptors, causing altered mood and perception. Immediate effects include hallucinations and euphoria, while long-term use may lead to psychological distress and cognitive changes. Research focuses on its psychoactive effects, therapeutic potential, and risks associated with its use.
 |
|
VIII. Culture
4-Bromo-2,5-dimethoxyamphetamine is a synthetic psychedelic, classifying it as a hallucinogen. Short-term use induces altered sensory perceptions and euphoria, while long-term use can lead to psychological effects and potential cognitive impairment. Overdose risks include severe agitation and psychosis. Safe dosages are not well-established, with lower doses advised. Recent research highlights its psychedelic effects but warns of potential for adverse psychological effects. Physical effects include altered perceptions, dilated pupils, and increased heart rate.
 |